|
Markt geschlossen -
Nasdaq
22:00:00 16.10.2026
|
Perf. 5 T | Veränd. 1. Jan. | ||
| 37.00 USD | -2.17% |
|
-0.19% | +20.13% |
| 16.10. | Nordische Aktien in Nordamerika - Ericsson steigt um 2,6 % | FW |
| 15.10. | Revolution Medicines' Europa-Offensive signalisiert Ambitionen für Alleingang bei Krebsmedikament | RE |
Hauptkonkurrenten
| % | % 5 Tage | Veränd. 1 Monat | Veränd. 3 Monate | % 1. Jan. | Perf. 1 Jahr | Perf. 3 Jahre | Veränd. 5 Jahre | Veränd. 10 Jahre | Marktkap.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -6.60% | -8.56% | -10.09% | +22.40% | +59.20% | +49.38% | +63.51% | -0.71% | - | 65 Mrd. | |
| +0.03% | +5.56% | +10.83% | +6.38% | +12.31% | +9.10% | +69.05% | -16.32% | +233.70% | 51.2 Mrd. | |
| -4.09% | -0.11% | -16.18% | -3.24% | +1.51% | +2.22% | +53.15% | +185.00% | +4’783.22% | 51.19 Mrd. | |
| -1.53% | +2.70% | -0.94% | +29.40% | +18.41% | +30.48% | +34.12% | +7.25% | +254.54% | 43.93 Mrd. | |
| -1.34% | +4.12% | +4.41% | +18.28% | +21.48% | +16.64% | +115.13% | +2.97% | +1’034.52% | 41.96 Mrd. | |
| -5.97% | -6.22% | -9.64% | -4.40% | +123.43% | +228.95% | +454.22% | +560.33% | - | 38.14 Mrd. | |
| +6.53% | +8.02% | +7.60% | +10.35% | +12.54% | +16.40% | +53.41% | +7.26% | +176.07% | 33.24 Mrd. | |
| -0.90% | -10.49% | -3.79% | +30.34% | +53.31% | +37.09% | -3.70% | -55.94% | - | 25.2 Mrd. | |
| -1.07% | +2.33% | +11.50% | +33.87% | +23.43% | +19.43% | +9.98% | -12.27% | +123.99% | 22.5 Mrd. | |
| -2.76% | -9.54% | -11.10% | -4.12% | -7.87% | -16.58% | -9.19% | -64.59% | - | 22.03 Mrd. | |
| -2.96% | -4.30% | -22.35% | -11.12% | -44.69% | -41.92% | +274.59% | +263.42% | +608.39% | 21.02 Mrd. | |
| -1.61% | +1.05% | +0.53% | +15.01% | +10.12% | +17.12% | +156.36% | +230.59% | +1’996.51% | 17.26 Mrd. | |
| +3.32% | +4.18% | +4.18% | +4.18% | +193.84% | +167.65% | +388.09% | +1’614.31% | +809.55% | 15.9 Mrd. | |
| -0.95% | +3.96% | +6.39% | +11.28% | +41.98% | +58.55% | +185.72% | +185.20% | +440.66% | 15.42 Mrd. | |
| -1.14% | +1.48% | +1.80% | +11.35% | +25.42% | +25.18% | +55.83% | -27.90% | +86.96% | 15.28 Mrd. | |
| -0.60% | -1.74% | -5.77% | -13.70% | - | - | - | - | - | 14.79 Mrd. | |
| -1.99% | -0.54% | +6.56% | +33.79% | +50.47% | +68.13% | +56.37% | -25.62% | +274.95% | 14.33 Mrd. | |
| +3.10% | +1.66% | -2.04% | -7.07% | +15.25% | -1.40% | +455.28% | - | - | 13.77 Mrd. | |
| -2.83% | +3.66% | +0.29% | +0.11% | -6.61% | -8.04% | -28.34% | -38.13% | +120.16% | 13.13 Mrd. | |
| Durchschnitt | -1.23% | +0.05% | -1.46% | +9.64% | +33.53% | +37.69% | +132.42% | +165.58% | +841.79% | 28.17 Mrd. | |
| Nach Marktkapitalisierung gewichteter Durchschnitt | -1.83% | -0.41% | -2.36% | +11.04% | +33.21% | +39.06% | +116.82% | +126.86% | +1’105.08% |
- Börse
- Aktien
- 565131 Aktie
- A1WZYB Aktie
- Sektor Genmab A/S
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
